Champions Oncology (CSBR) EBITDA (2010 - 2026)
Champions Oncology (CSBR) posted EBITDA of -$522000.0 for Q2 2026, down 89.13% on a QoQ basis from -$276000.0 in Q1 2026, and up 73.99% year-over-year from -$300015.5 in Q2 2025.
Powered by 
Analysis
Champions Oncology (CSBR) EBITDA (2010 - 2026) Analysis & Trends
Champions Oncology has reported EBITDA for 17 years, with the latest figure at -$522000.0 in Q2 2026.
- On a quarterly basis, EBITDA rose 73.99% year-over-year to -$522000.0 in Q2 2026; TTM through Apr 2026 was -$1.1 million, a 125.04% decrease from a year earlier, with the FY2026 full-year figure at -$1.1 million, down 125.04% from the prior year.
- EBITDA was -$522000.0 for Q2 2026 at Champions Oncology, down from -$276000.0 in the prior quarter.
- The five-year high for EBITDA was $4.5 million in Q1 2025, with the low at -$2.6 million in Q1 2024.
- Average EBITDA over 5 years is -$482166.7, with a median of -$297500.0 recorded in 2022.
- The sharpest annual moves came in 2023 and 2025: EBITDA slumped 28028.57% in 2023, then jumped 274.58% in 2025.
- Over 5 years, EBITDA stood at $7000.0 in 2022, then plunged by 28028.57% to -$2.0 million in 2023, then surged by 137.44% to $732000.0 in 2024, then slumped by 74.73% to $185000.0 in 2025, then tumbled by 382.16% to -$522000.0 in 2026.
- The last three EBITDA figures came in at -$522000.0 (Q2 2026), -$276000.0 (Q1 2026), and $185000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | 506.00 Mn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 153.38 Mn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | 119.89 Mn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | 327.25 Mn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | 14.80 Mn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | -58.55 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | -522,000.00 |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | -2.33 Mn |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | -2.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -522,000.00 |
| Jan 31, 2026 | -276,000.00 |
| Oct 31, 2025 | 185,000.00 |
| Jul 31, 2025 | -527,000.00 |
| Apr 30, 2025 | -2.01 Mn |
| Jan 31, 2025 | 4.50 Mn |
| Oct 31, 2024 | 732,000.00 |
| Jul 31, 2024 | 1.33 Mn |
| Apr 30, 2024 | -271,000.00 |
| Jan 31, 2024 | -2.58 Mn |
| Oct 31, 2023 | -1.96 Mn |
| Jul 31, 2023 | -2.55 Mn |
| Apr 30, 2023 | -2.52 Mn |
| Jan 31, 2023 | -2.46 Mn |
| Oct 31, 2022 | 7,000.00 |
| Jul 31, 2022 | -284,000.00 |
| Apr 30, 2022 | -311,000.00 |
| Jan 31, 2022 | 830,000.00 |
| Oct 31, 2021 | 263,000.00 |
| Jul 31, 2021 | -175,000.00 |